We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Notice for venetoclax (Abbvie Pty Ltd)
Active ingredients
venetoclax
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet, film-coated
Indication
Venetoclax is indicated for the treatment of patients with acute myeloid leukaemia (AML)
Therapeutic area
Haematology